Galle P et al. Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: Outcomes by liver disease aetiology front wo randomised, placebo-controlled phase 3 studies (REACH-2 and REACH). (Abstract GS-09)
Baby’s en kwetsbare ouderen vaccineren tegen RS-virus
apr 2023 | Ouderen, Vaccinatie, Virale infecties